LENZ Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 4.18 M | $120.64 M | 0.00% | 15.38% |
ALPHA WAVE GLOBAL, LP | 02/13/2025 | 3.61 M | $104.28 M | 0.00% | 13.29% |
BLACKROCK, INC. | 02/07/2025 | 1.16 M | $33.36 M | 24.26% | 4.25% |
72 INVESTMENT HOLDINGS, LLC | 02/14/2025 | 1.02 M | $29.38 M | 0.00% | 3.75% |
SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 986,981 | $28.49 M | -18.33% | 3.63% |
SECTORAL ASSET MANAGEMENT INC | 02/14/2025 | 977,245 | $28.21 M | 0.00% | 3.60% |
RTW INVESTMENTS, LP | 02/14/2025 | 863,389 | $24.93 M | 0.00% | 3.18% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 783,921 | $22.63 M | -9.37% | 2.89% |
PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 770,455 | $22.24 M | 100.00% | 2.84% |
TANG CAPITAL MANAGEMENT LLC | 02/14/2025 | 766,940 | $22.14 M | 0.00% | 2.82% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 334,026 | $9.65 M | -1.18% | 1.23% |
IKARIAN CAPITAL, LLC | 02/14/2025 | 149,502 | $4.32 M | -26.90% | 0.55% |
ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 142,113 | $4.10 M | 16.38% | 0.52% |
NORTHERN TRUST CORP | 02/14/2025 | 139,288 | $4.02 M | 7.44% | 0.51% |
TD ASSET MANAGEMENT INC | 02/11/2025 | 103,000 | $2.97 M | 263.83% | 0.38% |
MORGAN STANLEY | 02/14/2025 | 92,284 | $2.66 M | 82.82% | 0.34% |
MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 67,891 | $1.96 M | 116.84% | 0.25% |
VIVALDI CAPITAL MANAGEMENT LP | 02/14/2025 | 56,252 | $1.39 M | -4.26% | 0.21% |
GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 51,842 | $1.50 M | 100.00% | 0.19% |
HARBOR CAPITAL ADVISORS, INC. | 01/10/2025 | 43,989 | $1.27 M | 100.00% | 0.16% |
BBR PARTNERS, LLC | 02/07/2025 | 40,000 | $1.15 M | 0.00% | 0.15% |
BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 39,746 | $1.15 M | -26.91% | 0.15% |
BANK OF AMERICA CORP /DE/ | 02/14/2025 | 38,246 | $1.10 M | 92.67% | 0.14% |
AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 32,506 | $938,448 | 36.15% | 0.12% |
ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 29,305 | $846,035 | 100.00% | 0.11% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 28,216 | $814,596 | 14.60% | 0.10% |
KESTRA PRIVATE WEALTH SERVICES, LLC | 01/28/2025 | 27,304 | $788,266 | -0.73% | 0.10% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 25,366 | $732,316 | -48.51% | 0.09% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 23,130 | $667,763 | 0.00% | 0.09% |
DELTA INVESTMENT MANAGEMENT, LLC | 02/18/2025 | 19,241 | $555,488 | 100.00% | 0.07% |
RHUMBLINE ADVISERS | 01/30/2025 | 18,754 | $541,418 | 6.23% | 0.07% |
RAFFERTY ASSET MANAGEMENT, LLC | 02/14/2025 | 17,716 | $511,461 | 100.00% | 0.07% |
CITIGROUP INC | 02/12/2025 | 17,453 | $503,868 | 90.81% | 0.06% |
TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 17,079 | $493,071 | -33.04% | 0.06% |
KELLEHER FINANCIAL ADVISORS | 01/17/2025 | 17,023 | $491,454 | -18.05% | 0.06% |
RINKEY INVESTMENTS | 02/14/2025 | 15,186 | $438,420 | 0.00% | 0.06% |
BML CAPITAL MANAGEMENT, LLC | 02/07/2025 | 9,271 | $267,654 | -84.55% | 0.03% |
LEGAL & GENERAL GROUP PLC | 02/13/2025 | 8,742 | $252,382 | 703.49% | 0.03% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 8,485 | $244,962 | 100.00% | 0.03% |
GSA CAPITAL PARTNERS LLP | 02/07/2025 | 8,385 | $242,000 | -19.04% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 7,914 | $229,318 | 14.55% | 0.03% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 7,586 | $219,008 | -18.83% | 0.03% |
D. E. SHAW & CO., INC. | 02/14/2025 | 7,447 | $214,995 | 100.00% | 0.03% |
INTECH INVESTMENT MANAGEMENT LLC | 02/11/2025 | 7,446 | $214,966 | 100.00% | 0.03% |
COREBRIDGE FINANCIAL, INC. | 02/11/2025 | 6,245 | $180,293 | -7.01% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 01/24/2025 | 5,831 | $168,341 | 100.00% | 0.02% |
NEW YORK STATE COMMON RETIREMENT FUND | 01/31/2025 | 3,493 | $101,000 | 0.00% | 0.01% |
02/11/2025 | 2,525 | $72,897 | 100.00% | 0.01% | |
VIRTUS ETF ADVISERS LLC | 02/14/2025 | 2,309 | $66,661 | 100.00% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 1,860 | $53,698 | 162.34% | 0.01% |
LENZ Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 69 institutional investors and hedge funds held shares of LENZ Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 4.18 M
Alpha Wave Global, LP: 3.61 M
BlackRock, Inc.: 1.16 M
72 Investment Holdings, LLC: 1.02 M
Samsara BioCapital, LLC: 986,981
SECTORAL ASSET MANAGEMENT INC: 977,245
71.26% of LENZ Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 17.73 M shares in the last 24 months. This purchase volume represents approximately $359.19 M in transactions.